AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $35.51M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.10pm 28/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 3.4¢ | Day High | 3.4¢ | Day Low | 3.3¢ | |||
| Daily Volume | 772986 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 3.3¢ | 114285 | 0 | 3.4¢ | 45621 | |
Directors & Senior Management
| Mr. Andrew Corbett | MD, CEO & Director |
| Mr. Anthony Samuel Wehby | Independent Non-Executive Director |
| Mr. Barry Bourne | Consultant |
| Mr. Michael Francis Wilkes | Independent Non-Executive Chairman |
| Mr. Stuart Hayward | Chief Geologist |
| Mr. Stuart Rechner | Independent Non-Executive Director |
| Mr. Vinod Kumar Manikandan | Company Secretary |
Data source: ADVFN
